Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
WHEN TELEMETRY MISLEADS: THE VALUE OF CLINICAL EVALUATION IN DEVICE DECISION-MAKING AND HEART FAILURE MANAGEMENT
Anno:
2026
A 72-year-old woman was admitted for evaluation of hypokinetic dilated cardiomyopathy, along with heart failure with reduced ejection fraction (HFrEF). It was incidentally discovered during pre-operative cardiology assessment for carotid endarterectomy, due to critical left internal carotid stenosis. Her history included recurrent presyncopal episodes with prodromal symptoms and absence…
ORGANIZATIONAL MODEL OF THE HEART FAILURE OUTPATIENT CLINIC AT AORN CARDARELLI: FROM ACUTE MANAGEMENT TO THERAPEUTIC OPTIMIZATION
Anno:
2026
Background: Heart failure (HF) represents a significant clinical and economic burden, characterized by high rates of rehospitalization and mortality. Effective management requires a structured transition from acute care to specialized longitudinal follow-up. This abstract describes the organizational model of the Heart Failure Outpatient Clinic within the Cardiology and Intensive…
OPTIMIZING OUTPATIENT MANAGEMENT OF HEART FAILURE: REAL-WOLRD IMPLEMENTATION OG GUIDELINE-DIRECTED MEDICAL THERAPY, ANALYSIS FROM CARDARELLI HOSPITAL OF NAPLES
Anno:
2026
Background: Heart failure (HF) is a significant global health burden, characterized by high rates of hospitalization and mortality. Recent clinical guidelines emphasize the implementation of "The Four Pillars" of Guideline-Directed Medical Therapy (GDMT) to improve clinical outcomes and quality of life. The primary objective of this study is to…
REMOTE MOTIVATIONAL INTERVIEWING IN HEART FAILURE: A QUALITATIVE STUDY OF PATIENTS’ EXPERIENCES
Anno:
2026
Background Heart failure (HF) is a complex chronic condition requiring effective self-care behaviours to prevent adverse outcomes. Remote motivational interviewing (MI) may represent a sustainable and acceptable intervention to support self-care in individuals with HF, but the literature does not report how this type of intervention is experienced and…
ADHERENCE TO PHARMACOLOGICAL THERAPIES AND LIFESTYLE RECOMMENDATIONS AFTER HOSPITALIZATION FOR ACUTE HEART FAILURE: RESULTS OF THE DIMACC PROJECT
Anno:
2026
Background The first year after admission for Acute Heart Failure (AHF) is the most critical period, with high mortality and readmission rates, often favoured by discontinuation of prescribed therapies or poor adherence to lifestyle recommendations. The DIM ACC Project (“ Dim issioni Acc ompagnate”, i.e. Accompanied Discharge) was launched…
ROLE OF GLP1 AGONIST AFTER TAVI: INSIGHTS FROM MOTIVE REGISTRY
Anno:
2026
Introduction: GLP-1a are a novel class of cardiometabolic drugs that have been shown to reduce the risk of MACE and cardiovascular mortality in patients with type 2 diabetes, overweight, or obesity. Improved outcomes have also been reported in patients undergoing TAVI treated with the SGLT2 inhibitor dapagliflozin in the…
NON-INVASIVE CARDIAC HAEMODYNAMIC AND FLUID CONTENT SYSTEM (NICAS) AS A NEW METHOD FOR THE MANAGEMENT OF PATIENTS WITH HEART FAILURE
Anno:
2026
Background: Systemic congestion can be identified as a cause and result of worsening cardiovascular function.Being able to correctly identify the hemodynamic status of the patient can surely address the therapeutic process with early treatment adjustments.However,nowadays the gold standard includes invasive measurements.As an alternative,NiCas represents a valid new non-invasive technology…
EFFECTS OF SGLT2 INHIBITORS ON ATRIAL FUNCTION ASSESSED BY ECHOCARDIOGRAPHIC STRAIN IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
Anno:
2026
Background: Type 2 sodium-glucose cotransporter inhibitors (SGLT2i) have shown clinical benefits in patients affected by chronic heart failure (CHF), but the mechanisms underlying their beneficial effects are still debated. Over the last years, SGLT2i showed its ability to improve left and right ventricular function, whereas its impact on atrial…
TELEMONITORING FOR HEART FAILURE CARE: FEASIBILITY AND EARLY CLINICAL IMPACT OF “TELECUORE” PROGRAM
Anno:
2026
Background Telemedicine may improve heart failure (HF) management by enabling early detection of clinical instability and therapy optimization. The TeleCuore program was implemented at the Cardiology Unit of “Guglielmo da Saliceto” Hospital (Piacenza, Italy) to assess feasibility, clinical impact, and patient experience. Methods Patients discharged with de novo HF…
SUPRA-NORMAL EJECTION FRACTION AT HOSPITAL ADMISSION STRATIFIES MORTALITY RISK IN HFPEF PATIENTS AGED ≥70 YEARS
Anno:
2026
Background: During the last few years, significant pathophysiological differences between heart failure (HF) patients with “normal” ejection fraction (EF) (50% to 64%) and those with supra-normal EF (≥65%) have been highlighted. However, these distinct EF phenotypes have been poorly investigated in elderly patients aged ≥70 yrs. Accordingly, the present…